Abiraterone Acetate 50268-0032
Product NDC
50268-0032- Manufacturer
- Avpak
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 4, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA208416
Need to source Abiraterone Acetate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Abiraterone Acetate | 250 mg/1 |
Drug Class
Cytochrome P450 17A1 Inhibitor [EPC]Cytochrome P450 17A1 Inhibitors [MoA]Cytochrome P450 2C8 Inhibitors [MoA]
Packaging Options(1)
20 BLISTER PACK in 1 BOX (50268-032-12) / 1 TABLET in 1 BLISTER PACK (50268-032-11)